(Date:7/24/2008)...W YORK, July 24 /- American... announced that it plans to release,second quarter..., after the,market closes., The Company will hold...8 to discuss its fiscal second quarter 2008 result...599-9816 or 1-617-847-8705 for,international calle...
(Date:7/24/2008)...UTH SAN FRANCISCO, Calif., July 24 /PRNewswire-Fir... PARD ), a biopharmaceutical company focused,on on...ence call to discuss,the Company,s second quarter ...an update on the clinical development plan for pic...ry McMahon, Ph.D., chairman and chief,executive of...
(Date:7/24/2008)...HAUMBURG, Ill., July 24 /- Sagent Pha...rmaceutical company, today announced that it,has l...hetic,broad-spectrum, beta-lactam antibiotic. Sage...vials and 6g pharmacy bulk package vials. Accordin... in the United States were,approximately $45.7 mil...
(Date:7/24/2008)... Company reports double-digit sales and earnin...tCall/ -- Eli Lilly and Company,(NYSE: LLY ) toda...er of,2008., Second-quarter results are presented...ed in accordance with generally accepted accountin...nses recognized by the,company during the period. ...
Breaking Biology Technology:Poniard Pharmaceuticals to Host Second Quarter 2008 Financial Results Conference Call on July 31 2Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP 2Lilly Reports Solid Second-Quarter Results 2Lilly Reports Solid Second-Quarter Results 3Lilly Reports Solid Second-Quarter Results 4Lilly Reports Solid Second-Quarter Results 5Lilly Reports Solid Second-Quarter Results 6Lilly Reports Solid Second-Quarter Results 7Lilly Reports Solid Second-Quarter Results 8Lilly Reports Solid Second-Quarter Results 9Lilly Reports Solid Second-Quarter Results 10Lilly Reports Solid Second-Quarter Results 11Lilly Reports Solid Second-Quarter Results 12Lilly Reports Solid Second-Quarter Results 13Lilly Reports Solid Second-Quarter Results 14Lilly Reports Solid Second-Quarter Results 15Lilly Reports Solid Second-Quarter Results 16Lilly Reports Solid Second-Quarter Results 17Lilly Reports Solid Second-Quarter Results 18Lilly Reports Solid Second-Quarter Results 19Lilly Reports Solid Second-Quarter Results 20Lilly Reports Solid Second-Quarter Results 21...tal investments during 2005 in the biotech and med...pared against the general VC landscape. I also pro...ure Capital investments by region and stage of dev...for this analysis is provided once again by Price...probably useful for us to benchmark the Midwest ag...
... which makes computerized assessment and progress ...n Wednesday that president and CEO John Hickey, 50...nd CEO since 2003. , ,"There is never a right tim...ess release. "I know some people will be surprised...g I have been thinking about for some time. At 50 ...
...atement, consider this pledge from the bipartisan ...will not simply propose adding new dollars on top ...se of all dollars first those currently in the (K... dollars if that is the finding of the adequacy an...ive] , ,In other words, this blue-ribbon panel wo...
...spoke of energy during a visit to Wisconsin, but r...rces, his remarks were directed toward new methods... to foreign oil. , ,In an address before employees... battery manufacturer that is developing a new fue...y initiative he outlined during the State of the U...
Other Biology Technology:Midwest plays small role in VC investment, angel groups to the rescue 2Midwest plays small role in VC investment, angel groups to the rescue 3Midwest plays small role in VC investment, angel groups to the rescue 4Midwest plays small role in VC investment, angel groups to the rescue 5Measuring what works and what doesn't in the prototypical school 2Measuring what works and what doesn't in the prototypical school 3Bush praises Johnson Controls battery tech in Milwaukee visit 2(Date:7/24/2008)... telescope promise to make it easier for people wi...s requiring sharper distance vision. Schepens Eye ...ges of these innovative glasses over earlier devic...f Journal of Biomedical Optics , mailed in print...sign has several advantages," says the inventor of...
(Date:7/24/2008)...udy by researchers from Columbia University,s Mail...ost challenging issues in infant health and preven...tries. In these settings, HIV-infected mothers ha... infants, they should exclusively breast-feed, fol...birth. But according to the study conducted in Lus...
(Date:7/24/2008)...sylvania State University College of Medicine, Her...cy of imiquimod, a clinically important immune res... activity, is dependent on the Opioid Growth Facto...This discovery, reported in the August 08 issue of... insights into a widely used drug that may lead to...
(Date:7/24/2008)...entists at Harvard University and the University o...n is strongly shaped by genes, efforts to prevent ...r study also suggests that the cost of errors in p...s themselves, rather than the loss of functional p...ived cells, like neurons, and cause neurodegenerat...
Breaking Biology News(10 mins):Telescope embedded in glasses lens promises to make driving easier for visually impaired 2Telescope embedded in glasses lens promises to make driving easier for visually impaired 3Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Various species' genes evolve to minimize protein production errors 2Various species' genes evolve to minimize protein production errors 3Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca 1804 1Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca 1804 2Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca 1804 3Computerized Jump Rope Raises Funds for Breast Cancer Research 1800 1Computerized Jump Rope Raises Funds for Breast Cancer Research 1800 2Symbollon Pharmaceuticals Inc Evaluates the Clinical Effects of IoGen 28TM 29 on Fibrocystic Breast Disease 361 1Symbollon Pharmaceuticals Inc Evaluates the Clinical Effects of IoGen 28TM 29 on Fibrocystic Breast Disease 361 2Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency 1793 1Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency 1793 2Delhaize Group Selects Trintechs AssureNET GL to Improve Compliance Process Efficiency 1793 3...vered three molecules –?from a search of 58,000 co... of Alzheimer,s disease. , Each of the three molec...mes hopelessly tangled in the brains of patients w... the development of drugs for the disease. , Ken ...stitute at the University of California, Santa Bar...
... the mechanism by which the new genetically engine...d to the Vakzine Projekt Management who will test ...mechanisms for the high efficacy of this vaccine h...igations, August 18, 2005). , Globally, tuberculo...ver, multi-drug-resistant tuberculosis strains are...
...ists led by The Burnham Institute,s Maurizio Pelle...hrax toxin, termed lethal factor ("LF") that could...sure to inhalation anthrax. These findings will be...emy of Sciences by Early Edition at the journal,s ...s ("anthrax") is a proven agent of biological terr...
...rs, or Sultans of Soil, they,re just clever Lab gu... a paper in this week,s Science Magazine with a ne... the highly complex world beneath our feet. , "Com...ersity and High Metal Toxicity in Soil," by Jason ...os, Bioscience Division, describes a new approach ...
Other Biology News:Scientists discover that three molecules may be developed into new Alzheimer's drugs 2Scientists discover that three molecules may be developed into new Alzheimer's drugs 3Anthrax inhibitors identified by Burnham team 2Anthrax inhibitors identified by Burnham team 3Comparison of Cocaine, Methamphetamine ‘Highs?Finds Differences 2from yeast/leuconostoc overproducer ATP: D-hexose 6- phosphotransferase/D-glucose-6-phosphate: NADP 1-oxidoreductase EC 2.7.1.1/1.1.1.49. One unit of HK will phosphorylate 1 mol of D-glucose in 1 min
Request Info
Pyruvate Kinase. This product is expected to react with pyruvate kinase from other mammalian species but has not been specifically determined. Specificity: Gives a single precipitin line against pa
Features Convenient platform for tube handling and reagent dispensing Holds: - 96 x 0.2ml V-bottom tubes - 96 x 0.3ml U-bottom Omnistrips - Thermo-Tube Plates - Thermo-Fast®
Biology Products: